This study provides the first evidence that melanoma SK1 behaves as an immune escape lipid kinase, leading to an increased expression of immunosuppressive factors in the TME and impairing the response to anti-CTLA-4 or anti-PD-1 treatment. Here, PDCD1 is linked to melanoma.